Datta, R., Kuruvilla, M., Gill M., de la Morena M. Association of skin necrosis with subcutaneous immunoglobulin therapy. Annals of Allergy, Asthma & Immunology, 2014 July 31.
Datta R, Naura AS, Zerfaoui M, Errami Y, Oumouna M, Kim H, Ju J, Ronchi VP, Haas AL, Boulares AH. PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model. Allergy. 2011 Jan 28.
Naura AS, Datta R, Hans CP, Zerfaoui M, Rezk BM, Errami Y, Oumouna M, Matrougui K, Boulares AH. Reciprocal regulation of iNOS and PARP-1 during allergen-induced eosinophilia. Eur Respir J. 2009 Feb 1; 33(2): 252-62.
Oumouna-Benachour K, Hans CP, Suzuki Y, Naura A, Datta R, Belmadani S, Fallon K, Woods C, Boulares AH. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death. Circulation. 2007 May 8;115(18):2442-50.
Oumouna M, Datta R, Oumouna-Benachour K, Suzuki Y, Hans C, Matthews K, Fallon K, Boulares H. Poly(ADP-ribose) polymerase-1 inhibition prevents eosinophil recruitment by modulating Th2 cytokines in a murine model of allergic airway inflammation: a potential specific effect on IL-5. J Immunol. 2006 Nov 1;177(9):6489-96.
Posters and Presentations
Datta R. Gut commensal-dependent production of autoantibodies against the primordial lupus autoantigen Ro60 in the absence of mammalian Ro60. 2018 Annual Meeting of the American Association of Immunologists
Datta R. Immunological Monitoring in Smith-Magenis Syndrome – 2017 Clinical Immunology Society Annual Meeting
Datta R. Diagnosis of Multicentric Castleman's Disease: An Evaluation of a Patient with Polygammopathy - 2016 AAAAI Annual Meeting
Awards and Honors
2016, AAAAI Fellows in Training Travel Grant for Participation in the 2016 Annual Meeting
2009, F30 Grant – National Heart, Lung, and Blood Institute. Regulation of IL4 Signal Transduction by Poly(ADP-ribose) polymerase-1
2006, The McLaughlin Award from the Institute for Human Infections and Immunity - Best Oral Presentation on Immunology or Infectious Diseases
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.